Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for Precision Biosciences (DTIL) over the last 4 years, with Q3 2025 value amounting to $3000.0.

  • Precision Biosciences' Other Operating Expenses changed N/A to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$213000.0, marking a year-over-year increase of 7262.21%. This contributed to the annual value of -$436000.0 for FY2024, which is 542.3% up from last year.
  • Latest data reveals that Precision Biosciences reported Other Operating Expenses of $3000.0 as of Q3 2025.
  • Precision Biosciences' Other Operating Expenses' 5-year high stood at $72000.0 during Q2 2023, with a 5-year trough of -$524000.0 in Q4 2023.
  • Over the past 4 years, Precision Biosciences' median Other Operating Expenses value was -$15000.0 (recorded in 2022), while the average stood at -$68428.6.
  • Data for Precision Biosciences' Other Operating Expenses shows a peak YoY increase of 25319.15% (in 2023) and a maximum YoY decrease of 265789.47% (in 2023) over the last 5 years.
  • Precision Biosciences' Other Operating Expenses (Quarter) stood at -$19000.0 in 2022, then tumbled by 2657.89% to -$524000.0 in 2023, then skyrocketed by 65.27% to -$182000.0 in 2024, then soared by 101.65% to $3000.0 in 2025.
  • Its Other Operating Expenses stands at $3000.0 for Q3 2025, versus -$25000.0 for Q2 2025 and -$9000.0 for Q1 2025.